CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event – Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The ...
A bipartisan group of senators is working to draft legislation to reform a fast-growing hospital drug discount program designed to help low-income patients.
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Mayo Clinic on MSN
COVID-19 vaccines: Get the facts
The 2025-2026 COVID-19 vaccines available in the United States include Moderna, Pfizer-BioNTech and Novavax. The vaccines are all approved for people age 65 and older. Each vaccine also is approved ...
COVID-19 vaccines may enhance immune responses in some cancer patients, improving tumor treatment outcomes, according to new ...
The latest vaccines share similar safety profiles as their predecessors. Read more at straitstimes.com. Read more at ...
The findings revealed that the molecule that powers those specific vaccines, mRNA, has been shown to help the immune system ...
Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate ...
Getting a COVID shot in Florida has been tricky in the last few months amid changing guidelines. Here's what to know now.
Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers' 2025 Top Employers Survey for the eleventh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback